The scope of China’s personalized cosmetic service pilot programme has been further expanded recently, covering 23 provinces, autonomous regions and municipalities nationwide. CIRS Group has sorted out relevant pilot policies for your reference.
Phase I Pilot Programme
On November 10, 2022, the National Medical Products Administration (NMPA) launched the pilot programme for personalized cosmetic services in five provincial-level regions including Beijing, Shanghai, Zhejiang, Shandong and Guangdong.
The one-year pilot ran from November 2022 onwards, focusing on the following tasks:
- Explore operational models for personalized cosmetic services. Give full play to the market role of industry entities, and encourage pilot enterprises to carry out trials on skin diagnosis, product follow-up tracking and customized skincare regimens for general cosmetics such as colour cosmetics and skincare products.
- Develop effective regulatory measures tailored to personalized cosmetic service models. Drug regulatory authorities of each pilot region are encouraged to innovate supervision mechanisms under the existing cosmetic regulatory framework, and optimize supervision approaches covering product filing, testing, sample retention and sales administration.
- Formulate normative documents governing personalized cosmetic services. Based on pilot outcomes, reasonably streamline procedures while complying with statutory requirements on cosmetic filing, production supervision and risk monitoring. The initiative aims to guarantee cosmetic quality and safety while addressing consumers’ personalized cosmetic needs.
Phase II Pilot Programme
On September 17, 2025, the National Medical Products Administration (NMPA) rolled out the second phase of the personalized cosmetic service pilot scheme across 15 provinces, municipalities and autonomous regions, namely Beijing, Tianjin, Hebei, Heilongjiang, Shanghai, Zhejiang, Shandong, Henan, Hunan, Guangdong, Guangxi, Hainan, Chongqing, Yunnan and Shaanxi.
This two-year pilot commenced on October 1, 2025. Cosmetic filers or domestic responsible persons authorized by overseas filers may, within their proprietary retail premises such as exclusive stores and direct-sale outlets, provide on-site small-batch simple blending and repackaging services involving two or more types of filed general cosmetics in response to consumers’ personalized demands.
Expansion of the Scope of Phase II Pilot
On July 10, 2026, the NMPA issued a circular to expand the coverage of the second-phase pilot. Starting from August 1, 2026, eight additional provinces and autonomous regions including Liaoning, Jiangsu, Anhui, Fujian, Jiangxi, Hubei, Sichuan and Xinjiang have been incorporated into the pilot programme, with the pilot period lasting until September 30, 2027.
CIRS Reminder
The pilot programme for personalized cosmetic services has expanded to cover 23 provinces, autonomous regions and municipalities. Implemented in multiple phases, the pilot duration and regulatory requirements vary across regions.
Cosmetic manufacturers and distributors are advised to promptly get familiar with local pilot policies, fulfil primary responsibility for product quality and safety, carry out personalised cosmetic services in full compliance with regulations, and keep track of the latest regulatory updates to mitigate operational risks.
About CIRS
Established in 2007, the CIRS Group is a leading product safety and regulatory consulting firm. CIRS has branch offices in the Republic of Ireland, South Korea, the United States, the United Kingdom, Japan and China. CIRS Group utilizes its technical expertise, various resources, and international network to provide one-stop compliance services from regulatory compliance, laboratory testing, R&D to data services across multiple industries. This includes chemicals, cosmetics, food and food beverages, medical devices, agrochemical products, disinfectants, and consumer goods. It helps clients gain a competitive advantage by reducing business risks associated with regulatory affairs.
The CIRS cosmetic team provides expert support to ensure that cosmetic products meet stringent global cosmetic regulations and safety standards.
We offer comprehensive, lifecycle-based solutions for personal care products, from early-stage cosmetic ingredient development through to final product registration. Our services include:
- Cosmetic ingredient development and regulatory strategy,
- Physical/chemical and analytical tests,
- Toxicological tests (in vivo & in vitro),
- Efficacy and claim substantiation studies (in vivo & in vitro), and
- Ingredient and product registration across global markets.
With deep expertise in cosmetic regulatory compliance and safety evaluations, our team enables brands to bring products to market efficiently and with confidence.
Our Services
- China Cosmetics Registration and Filing
- China New Cosmetic Ingredients Registration and Filing
- China Toothpaste Filing
- Cosmetics Safety Test
- Cosmetics Efficacy Claims Test
- Micrological analysis
- Physicochemical Analysis
- Being a Domestic Responsible Person
- Safety Assessment Report
- Cosmetic Ingredient Quality and Safety Info Code Application
- Formula/Label/Ingredient Review
- Regulatory Consulting/Reporting/Training
- Custom Clearance
If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.
Further Information
